Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Mitochondrial Biology and Neurological Diseases.

Arun S, Liu L, Donmez G.

Curr Neuropharmacol. 2016;14(2):143-54.

PMID:
26903445
2.

Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies.

Bras J, Guerreiro R, Darwent L, Parkkinen L, Ansorge O, Escott-Price V, Hernandez DG, Nalls MA, Clark LN, Honig LS, Marder K, Van Der Flier WM, Lemstra A, Scheltens P, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Ortega-Cubero S, Pastor P, Ferman TJ, Graff-Radford NR, Ross OA, Barber I, Braae A, Brown K, Morgan K, Maetzler W, Berg D, Troakes C, Al-Sarraj S, Lashley T, Compta Y, Revesz T, Lees A, Cairns N, Halliday GM, Mann D, Pickering-Brown S, Dickson DW, Singleton A, Hardy J.

Hum Mol Genet. 2014 Dec 1;23(23):6139-46. doi: 10.1093/hmg/ddu334. Epub 2014 Jun 27.

3.

LRRK2 kinase activity regulates synaptic vesicle trafficking and neurotransmitter release through modulation of LRRK2 macro-molecular complex.

Cirnaru MD, Marte A, Belluzzi E, Russo I, Gabrielli M, Longo F, Arcuri L, Murru L, Bubacco L, Matteoli M, Fedele E, Sala C, Passafaro M, Morari M, Greggio E, Onofri F, Piccoli G.

Front Mol Neurosci. 2014 May 27;7:49. doi: 10.3389/fnmol.2014.00049. eCollection 2014.

4.

Leucine-rich repeat kinase 2 binds to neuronal vesicles through protein interactions mediated by its C-terminal WD40 domain.

Piccoli G, Onofri F, Cirnaru MD, Kaiser CJ, Jagtap P, Kastenmüller A, Pischedda F, Marte A, von Zweydorf F, Vogt A, Giesert F, Pan L, Antonucci F, Kiel C, Zhang M, Weinkauf S, Sattler M, Sala C, Matteoli M, Ueffing M, Gloeckner CJ.

Mol Cell Biol. 2014 Jun;34(12):2147-61. doi: 10.1128/MCB.00914-13. Epub 2014 Mar 31.

5.

RISC in PD: the impact of microRNAs in Parkinson's disease cellular and molecular pathogenesis.

Heman-Ackah SM, Hallegger M, Rao MS, Wood MJ.

Front Mol Neurosci. 2013 Nov 20;6:40. doi: 10.3389/fnmol.2013.00040. Review.

6.

Mutant LRRK2 elicits calcium imbalance and depletion of dendritic mitochondria in neurons.

Cherra SJ 3rd, Steer E, Gusdon AM, Kiselyov K, Chu CT.

Am J Pathol. 2013 Feb;182(2):474-84. doi: 10.1016/j.ajpath.2012.10.027. Epub 2012 Dec 8.

7.

Genetics of Parkinson's disease.

Klein C, Westenberger A.

Cold Spring Harb Perspect Med. 2012 Jan;2(1):a008888. doi: 10.1101/cshperspect.a008888. Review.

8.

Imbalanced estrogen metabolism in the brain: possible relevance to the etiology of Parkinson's disease.

Gaikwad NW, Murman D, Beseler CL, Zahid M, Rogan EG, Cavalieri EL.

Biomarkers. 2011 Aug;16(5):434-44. doi: 10.3109/1354750X.2011.588725. Epub 2011 Jun 21.

9.

Heritability of Parkinson disease in Swedish twins: a longitudinal study.

Wirdefeldt K, Gatz M, Reynolds CA, Prescott CA, Pedersen NL.

Neurobiol Aging. 2011 Oct;32(10):1923.e1-8. doi: 10.1016/j.neurobiolaging.2011.02.017. Epub 2011 Apr 11.

10.

Insight into the mode of action of the LRRK2 Y1699C pathogenic mutant.

Daniëls V, Vancraenenbroeck R, Law BM, Greggio E, Lobbestael E, Gao F, De Maeyer M, Cookson MR, Harvey K, Baekelandt V, Taymans JM.

J Neurochem. 2011 Jan;116(2):304-15. doi: 10.1111/j.1471-4159.2010.07105.x.

11.

LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's disease.

Yao C, El Khoury R, Wang W, Byrd TA, Pehek EA, Thacker C, Zhu X, Smith MA, Wilson-Delfosse AL, Chen SG.

Neurobiol Dis. 2010 Oct;40(1):73-81. doi: 10.1016/j.nbd.2010.04.002. Epub 2010 Apr 9.

12.

Mutations in the GIGYF2 (TNRC15) gene at the PARK11 locus in familial Parkinson disease.

Lautier C, Goldwurm S, Dürr A, Giovannone B, Tsiaras WG, Pezzoli G, Brice A, Smith RJ.

Am J Hum Genet. 2008 Apr;82(4):822-33. doi: 10.1016/j.ajhg.2008.01.015. Epub 2008 Mar 20.

13.

Analysis of Parkinson disease patients from Portugal for mutations in SNCA, PRKN, PINK1 and LRRK2.

Bras J, Guerreiro R, Ribeiro M, Morgadinho A, Januario C, Dias M, Calado A, Semedo C, Oliveira C, Hardy J, Singleton A.

BMC Neurol. 2008 Jan 22;8:1. doi: 10.1186/1471-2377-8-1.

14.

The Parkinson's disease-associated protein, leucine-rich repeat kinase 2 (LRRK2), is an authentic GTPase that stimulates kinase activity.

Guo L, Gandhi PN, Wang W, Petersen RB, Wilson-Delfosse AL, Chen SG.

Exp Cell Res. 2007 Oct 1;313(16):3658-70. Epub 2007 Jul 19.

15.

LRRK2 in Parkinson's disease and dementia with Lewy bodies.

Zhu X, Babar A, Siedlak SL, Yang Q, Ito G, Iwatsubo T, Smith MA, Perry G, Chen SG.

Mol Neurodegener. 2006 Nov 30;1:17.

Items per page

Supplemental Content

Write to the Help Desk